ask="0.3850"
ask_size="3000"
average_daily_volume="2104430"
bid="0.2630"
bid_size="900"
book_value="0.1680"
change="+0.0026"
change_from_200_day_moving_average="0.0286"
change_from_50_day_moving_average="0.0613"
change_from_52_week_high="-0.7472"
change_From_52_week_low="0.0908"
change_in_percent="+0.7023%"
close="0.3728"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3825"
high_52_weeks="1.1200"
last_trade_date="2/14/2017"
last_trade_price="0.3728"
last_trade_size="1100"
last_trade_time="4:00pm"
low="0.3610"
low_52_weeks="0.2820"
market_capitalization="95.86M"
moving_average_200_day="0.3442"
moving_average_50_day="0.3115"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3710"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+8.2984%"
percent_change_from_50_day_moving_average="+19.6901%"
percent_change_from_52_week_high="-66.7143%"
percent_change_from_52_week_low="+32.1986%"
previous_close="0.3702"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.2036"
price_per_sales="1.7476"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="PPHM"
volume="2198103"
weeks_range_52="0.2820 - 1.1200"
